Bayer: U.S. Government Strengthens Position in Glyphosate Dispute and Increases Chances for Supreme Court Decision!

Bayer AG has made a significant advancement in the long-standing billion-dollar dispute regarding the alleged cancer risks of the glyphosate-containing product Roundup. As the White House stated on Monday, Washington supports Bayer's efforts to take the case to the Supreme Court. For Bayer, this would be the first opportunity for a structural solution to a legal risk that has continuously troubled the company since the Monsanto acquisition in 2018 and burdened the capital market. The political backing from Washington noticeably shifts the playing...